CDK 4/6 Inhibitors in Metastatic Breast Cancer
1 Visningar
• 07/03/23
0
0
Bädda in
administrator
Prenumeranter
Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna